U.S. markets closed

Collegium Pharmaceutical, Inc. (COLL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
24.61-0.54 (-2.15%)
At close: 4:00PM EDT
24.61 0.00 (0.00%)
After hours: 04:46PM EDT
Sign in to post a message.
  • Y
    Yahoo Finance Insights
    Collegium Pharmaceutical is up 5.47% to 25.47
  • s
    sarah
    Break out? Is it possible we get a “mini shortsqueeze”?
    Based on fundamentals, the numbers say there’s no reason why we can’t breech 30??
    ...wondering if insiders or institutions are accumulating?
  • P
    PSea
    mgmt has failed to translate operational execution into shareholder value.
    ...but they sure like getting free stock #RobbingShareholders
  • O
    Ou812
    just wanted to share some, positive, info about Colligium. I work for an excipient manufacturer who supplies Collegium with their beeswax for Xtampza.. They have recently asked us to move up their next delivery and have also ask to increase their order by 3X. sounds like they are gearing up for a big 2020

    GLTA
    Bullish
  • P
    PSea
    DEAD money. Mgmt only interested in lining their own pockets. Quite a shame. Just the opportunity cost alone of staying invested here is a huge downside.
  • Y
    Yahoo Finance Insights
    Collegium Pharmaceutical is up 5.38% to 24.79
  • S
    Surepick
    Added more shares today - didn't really plan to as I have a full position already. Just too good an opportunity to pass up at these prices.
  • S
    Sarah
    Cantor Fitzgerald maintains its buy rating of COLL today with a price target of $35.
    "We are reiterating our Overweight rating and 12-month price target of $35 post COLL issuing 2019 revenue guidance below FactSet consensus, and our estimates. We remain positive on the long-term growth potential of Xtampza, and we believe that Xtampza will replace OxyContin as the largest branded oxycodone ER product over time with COLL building itself into one of the leading specialist pain companies.”
  • e
    eddy
    Big day tomorrow
  • O
    Ou812
    Well earnings at first glance looked good. Any comments on the CC.

    It’ll be interesting to see how this trades.

    Here for the long haul.
  • T
    The Tank
    Down in low volume. Time to pick more up
    Earnings early August
    Show profit?? Thoughts
  • S
    Surepick
    Nice jump in price after the guidance update. Hope this is the beginning of a nice run, been waiting a good while!
    Bullish
  • e
    eddy
    Up on a huge down day
  • S
    Self-Esteem
    Harry Boxer has posted his Charts of the Day video on COLL at TheTechTrader site noting: Collegium Pharmaceutical, Inc. (COLL) had a really good day on Tuesday considering biotech’s got hammered. It was up 1.11, or 5.54%, to 21.13, on a solid 655,833 shares traded. It needs to be a little bit better than that. I’m still looking for 23, 25, and 29 going forward.
  • s
    sharon
    one of the better performers in the market today and i am still long!! booyah.....................
  • P
    Peter
    Not a clue whether I should hold my 500 shares or sell before ER
  • e
    eddy
    Still concerned with super high salaries of executives. Stepped back from stock a few weeks back. Will watch earnings.
  • T
    That Englishman
    What’s going on? Big Pop today
  • e
    eddy
    $500 million market cap $350 million in revenue. Ok
  • R
    Richard
    Heffernan continues to sell his share. This is what is keeping the stock down. Apparently, he thinks his company is overvalued...